Belinostat på ASCO
42053 Gorm 3/5 2011 08:35
Læs mere om
på deres investorprofil. Tryk her
"Spectrum Pharmaceuticals has two approved and marketed drugs, FUSILEV (obtaining recent April 29th FDA approval for expanded use of the drug to treat advanced metastatic colon cancer) and ZEVALIN. However their focus at ASCO [18 maj] this year will likely be two drugs in late-stage development, Belinostat and Apaziquone."
http://www.investorvillage.com/smbd.asp?mb=569&mn=280..
Sendt fra ProInvestor gruppen
http://www.investorvillage.com/smbd.asp?mb=569&mn=280..
Sendt fra ProInvestor gruppen





